Literature DB >> 7926582

Chlorimipramine and nortriptyline but not fluoxetine and fluvoxamine inhibit human polymorphonuclear cell chemotaxis in vitro.

P Sacerdote1, M Bianchi, A E Panerai.   

Abstract

We examined the ability of antidepressant drugs belonging to different classes to interfere with human polymorphonuclear cell migration in vitro. 1. The tricyclic antidepressant drugs chlorimipramine and nortriptyline were able to block, in a dose related fashion both spontaneous and formyl-methionyl-leucyl-phenylalanine stimulated migration. This effect was already evident at very low concentrations (10(-7)M). 2. The atypical non-tricyclic antidepressant drugs fluoxetine and fluvoxamine did not affect polymorphonuclear cell mobility. 3. The ability of antidepressant drugs to interfere with polymorphonuclear cell physiology seems to depend on their chemical structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926582     DOI: 10.1016/0306-3623(94)90188-0

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

1.  Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi
Journal:  Psychoneuroendocrinology       Date:  2017-01-24       Impact factor: 4.905

2.  Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat.

Authors:  M Bianchi; G Rossoni; P Sacerdote; A E Panerai; F Berti
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

3.  Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate.

Authors:  Yohei Takenaka; Ryu Tanaka; Kazuki Kitabatake; Kouji Kuramochi; Shin Aoki; Mitsutoshi Tsukimoto
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

4.  Desipramine protects neuronal cell death and induces heme oxygenase-1 expression in Mes23.5 dopaminergic neurons.

Authors:  Hsiao-Yun Lin; Wei-Lan Yeh; Bor-Ren Huang; Chingju Lin; Chih-Ho Lai; Ho Lin; Dah-Yuu Lu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

5.  Anti-inflammatory properties of desipramine and fluoxetine.

Authors:  Caroline Roumestan; Alain Michel; Florence Bichon; Karine Portet; Maëlle Detoc; Corinne Henriquet; Dany Jaffuel; Marc Mathieu
Journal:  Respir Res       Date:  2007-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.